+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
At-home Drug of Abuse Testing Market by Distribution Channel, Test Type, Sample Type, Technology, End User - Global Forecast to 2030- Product Image
At-home Drug of Abuse Testing Market by Distribution Channel, Test Type, Sample Type, Technology, End User - Global Forecast to 2030- Product Image
Sale

At-home Drug of Abuse Testing Market by Distribution Channel, Test Type, Sample Type, Technology, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 198 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5716235
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The at-home drug-of-abuse testing market is entering a new phase of transformation, driven by advances in technology, changing regulatory landscapes, and increased demand for convenient, reliable screening solutions among enterprises and individual users.

Market Snapshot: At-home Drug of Abuse Testing Market

In 2024, the global at-home drug-of-abuse testing market stood at USD 2.88 billion, advancing to USD 3.10 billion in 2025 and projected to reach USD 4.38 billion by 2030, reflecting a CAGR of 7.24%. High adoption is being influenced by privacy concerns, faster result needs, and integration into occupational, healthcare, and consumer settings. Shifts toward decentralized diagnostics echo trends in personalized medicine, while improved immunoassay techniques, mobile platforms, and digital readouts enhance test accessibility and reliability for a broad range of professional and personal use cases.

Scope & Segmentation

  • Distribution Channels: Online avenues including e-commerce platforms and manufacturer websites; pharmacy retail, covering both chain and independent stores
  • Test Types: Multi-drug panels (three, five, and ten analytes), and single-substance assays for amphetamines, cocaine, marijuana, and opiates
  • Sample Types: Hair, saliva (oral fluid dip cards and swabs), sweat, and urine
  • Technologies: Chromatography (gas and liquid chromatography-mass spectrometry), competitive and sandwich immunoassays, and lateral flow (conventional and digital) formats
  • End Users: Clinics (including occupational programs and substance abuse clinics), individual consumers, pharmacies (chain and independent)
  • Regions Covered: Americas (with detailed focus on U.S. states and major countries in North and South America), Europe, Middle East & Africa (key countries including the UK, Germany, France, and emerging economies), and Asia-Pacific (spanning leading markets such as China, India, Japan, Australia, and Southeast Asian countries)
  • Key Companies Analyzed: Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Abbott Rapid Diagnostics, Premier Biotech, American Screening Corporation, Express Diagnostics International, Access Bio Inc., Diagnostic Automation/Cortez Diagnostics, Certest Biotec S.L., and Nal von Minden GmbH

Key Takeaways for Senior Decision-Makers

  • Integration of digital health tools and smartphone connectivity streamlines self-testing, result interpretation, and secure data sharing for both clinical and direct-to-consumer segments.
  • Direct sales channels are accelerating, empowering manufacturers to reach end users without third-party distribution layers while ensuring greater brand presence online and in-store.
  • Growing adoption of saliva- and sweat-based noninvasive tests aligns with customer expectations for convenience and mobile use, addressing extended and real-time monitoring needs.
  • Collaborations between diagnostics leaders and technology startups are fast-tracking the deployment of laboratory-grade tests with enhanced data analytics and clinician dashboard integration.
  • Regional market maturity varies significantly. The Americas benefit from robust infrastructure and clear regulatory pathways, while Asia-Pacific’s rapid healthcare modernization and digital literacy drive new opportunities for local and international suppliers.

Tariff Impact on Supply Chains

The 2025 introduction of U.S. tariffs on imported test components heightened production costs, pressuring manufacturers to optimize sourcing and pricing structures. This led to accelerated partnerships with domestic suppliers, a shift to bulk procurement strategies, and a renewed emphasis on supply chain diversification. Innovation with alternative materials and cost-containment measures emerged as critical strategies to sustain profitability and market presence amid evolving trade policies.

Methodology & Data Sources

This analysis is built on extensive primary research, including interviews with laboratory leaders, clinicians, procurement managers, and end users, supplemented by in-depth quantitative surveys. Rigorous secondary research involved a thorough review of regulatory filings, patent databases, industry publications, and financial disclosures. Data triangulation and iterative peer reviews support the credibility and depth of market insights presented.

Why This Report Matters

  • Provides actionable intelligence for product and portfolio development in the at-home drug-of-abuse testing market, supporting strategic planning and investment decisions.
  • Enables benchmarking of supply chain strategies, technology adoption, and competitive positioning across major global regions and distribution channels.
  • Delivers insights to help stakeholders navigate regulatory complexity, accelerating market entry and compliance in a fast-evolving sector.

Conclusion

Rapid digitalization, diversified sampling methods, and agile supply strategies are shaping the future of at-home drug testing. Strategic adaptation to shifting market, regulatory, and supply chain dynamics will determine competitive success. Leverage these insights to guide informed, data-driven decisions now and ahead.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. At-home Drug of Abuse Testing Market, by Distribution Channel
8.1. Introduction
8.2. Online
8.2.1. Ecommerce Platforms
8.2.2. Manufacturer Websites
8.3. Pharmacy Retail
8.3.1. Chain Pharmacy
8.3.2. Independent Pharmacy
9. At-home Drug of Abuse Testing Market, by Test Type
9.1. Introduction
9.2. Multi-Drug Panel
9.2.1. Five Panel
9.2.2. Ten Panel
9.2.3. Three Panel
9.3. Single Drug
9.3.1. Amphetamines
9.3.2. Cocaine
9.3.3. Marijuana
9.3.4. Opiates
10. At-home Drug of Abuse Testing Market, by Sample Type
10.1. Introduction
10.2. Hair
10.3. Saliva
10.3.1. Oral Fluid Dip Card
10.3.2. Saliva Swab
10.4. Sweat
10.5. Urine
11. At-home Drug of Abuse Testing Market, by Technology
11.1. Introduction
11.2. Chromatography
11.2.1. Gas Chromatography-Mass Spectrometry
11.2.2. Liquid Chromatography-Mass Spectrometry
11.3. Immunoassay
11.3.1. Competitive
11.3.2. Sandwich
11.4. Lateral Flow
11.4.1. Conventional
11.4.2. Digital
12. At-home Drug of Abuse Testing Market, by End User
12.1. Introduction
12.2. Clinics
12.2.1. Occupational Programs
12.2.2. Substance Abuse Clinics
12.3. Individuals
12.4. Pharmacies
12.4.1. Chain
12.4.2. Independent
13. Americas At-home Drug of Abuse Testing Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa At-home Drug of Abuse Testing Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific At-home Drug of Abuse Testing Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Laboratory Corporation of America Holdings
16.3.2. Quest Diagnostics Incorporated
16.3.3. Abbott Rapid Diagnostics
16.3.4. Premier Biotech, LLC
16.3.5. American Screening Corporation
16.3.6. Express Diagnostics International, LLC
16.3.7. Access Bio Inc.
16.3.8. Diagnostic Automation/Cortez Diagnostics, Inc.
16.3.9. Certest Biotec S.L.
16.3.10. Nal von Minden GmbH
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. AT-HOME DRUG OF ABUSE TESTING MARKET MULTI-CURRENCY
FIGURE 2. AT-HOME DRUG OF ABUSE TESTING MARKET MULTI-LANGUAGE
FIGURE 3. AT-HOME DRUG OF ABUSE TESTING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 14. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. AT-HOME DRUG OF ABUSE TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. AT-HOME DRUG OF ABUSE TESTING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. AT-HOME DRUG OF ABUSE TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ECOMMERCE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MANUFACTURER WEBSITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY FIVE PANEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEN PANEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY THREE PANEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY AMPHETAMINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COCAINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MARIJUANA, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY OPIATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY HAIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ORAL FLUID DIP CARD, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA SWAB, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SWEAT, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY URINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY GAS CHROMATOGRAPHY-MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COMPETITIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SANDWICH, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LATERAL FLOW, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CONVENTIONAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DIGITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LATERAL FLOW, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY OCCUPATIONAL PROGRAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SUBSTANCE ABUSE CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY INDIVIDUALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY INDEPENDENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LATERAL FLOW, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LATERAL FLOW, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 90. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 91. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 92. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, 2018-2030 (USD MILLION)
TABLE 93. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 94. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, 2018-2030 (USD MILLION)
TABLE 95. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, 2018-2030 (USD MILLION)
TABLE 96. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 97. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 98. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 99. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 100. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 101. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LATERAL FLOW, 2018-2030 (USD MILLION)
TABLE 102. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 103. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 104. CANADA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 105. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 106. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 107. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, 2018-2030 (USD MILLION)
TABLE 108. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 109. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, 2018-2030 (USD MILLION)
TABLE 110. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, 2018-2030 (USD MILLION)
TABLE 111. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 112. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 113. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 114. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 115. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 116. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LATERAL FLOW, 2018-2030 (USD MILLION)
TABLE 117. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 119. MEXICO AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LATERAL FLOW, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, 2018-2030 (USD MILLION)
TABLE 138. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 139. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, 2018-2030 (USD MILLION)
TABLE 141. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 142. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 143. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 144. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 145. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 146. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LATERAL FLOW, 2018-2030 (USD MILLION)
TABLE 147. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 148. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 149. ARGENTINA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LATERAL FLOW, 2018-2030 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 166. UNITED KINGDOM AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 168. UNITED KINGDOM AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, 2018-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 170. UNITED KINGDOM AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, 2018-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, 2018-2030 (USD MILLION)
TABLE 172. UNITED KINGDOM AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 174. UNITED KINGDOM AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 176. UNITED KINGDOM AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LATERAL FLOW, 2018-2030 (USD MILLION)
TABLE 178. UNITED KINGDOM AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 180. UNITED KINGDOM AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 181. GERMANY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 182. GERMANY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 183. GERMANY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, 2018-2030 (USD MILLION)
TABLE 184. GERMANY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 185. GERMANY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, 2018-2030 (USD MILLION)
TABLE 186. GERMANY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, 2018-2030 (USD MILLION)
TABLE 187. GERMANY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 188. GERMANY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 189. GERMANY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 190. GERMANY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 191. GERMANY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 192. GERMANY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LATERAL FLOW, 2018-2030 (USD MILLION)
TABLE 193. GERMANY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. GERMANY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 195. GERMANY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 196. FRANCE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 197. FRANCE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 198. FRANCE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, 2018-2030 (USD MILLION)
TABLE 199. FRANCE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 200. FRANCE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, 2018-2030 (USD MILLION)
TABLE 201. FRANCE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, 2018-2030 (USD MILLION)
TABLE 202. FRANCE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 203. FRANCE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 204. FRANCE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 205. FRANCE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 206. FRANCE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 207. FRANCE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LATERAL FLOW, 2018-2030 (USD MILLION)
TABLE 208. FRANCE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. FRANCE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 210. FRANCE AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 211. RUSSIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 212. RUSSIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 213. RUSSIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, 2018-2030 (USD MILLION)
TABLE 214. RUSSIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 215. RUSSIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, 2018-2030 (USD MILLION)
TABLE 216. RUSSIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, 2018-2030 (USD MILLION)
TABLE 217. RUSSIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 218. RUSSIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 219. RUSSIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 220. RUSSIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 221. RUSSIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 222. RUSSIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LATERAL FLOW, 2018-2030 (USD MILLION)
TABLE 223. RUSSIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 224. RUSSIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 225. RUSSIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 226. ITALY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 227. ITALY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 228. ITALY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, 2018-2030 (USD MILLION)
TABLE 229. ITALY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 230. ITALY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, 2018-2030 (USD MILLION)
TABLE 231. ITALY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, 2018-2030 (USD MILLION)
TABLE 232. ITALY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 233. ITALY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 234. ITALY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 235. ITALY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 236. ITALY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 237. ITALY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LATERAL FLOW, 2018-2030 (USD MILLION)
TABLE 238. ITALY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. ITALY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 240. ITALY AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 241. SPAIN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 242. SPAIN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 243. SPAIN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, 2018-2030 (USD MILLION)
TABLE 244. SPAIN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 245. SPAIN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, 2018-2030 (USD MILLION)
TABLE 246. SPAIN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, 2018-2030 (USD MILLION)
TABLE 247. SPAIN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 248. SPAIN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 249. SPAIN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 250. SPAIN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 251. SPAIN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 252. SPAIN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LATERAL FLOW, 2018-2030 (USD MILLION)
TABLE 253. SPAIN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 254. SPAIN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 255. SPAIN AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, 2018-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, 2018-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, 2018-2030 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 263. UNITED ARAB EMIRATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 265. UNITED ARAB EMIRATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LATERAL FLOW, 2018-2030 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 272. SAUDI ARABIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, 2018-2030 (USD MILLION)
TABLE 274. SAUDI ARABIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, 2018-2030 (USD MILLION)
TABLE 276. SAUDI ARABIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, 2018-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 278. SAUDI ARABIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 279. SAUDI ARABIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 280. SAUDI ARABIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 281. SAUDI ARABIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 282. SAUDI ARABIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LATERAL FLOW, 2018-2030 (USD MILLION)
TABLE 283. SAUDI ARABIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 284. SAUDI ARABIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 285. SAUDI ARABIA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 286. SOUTH AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 288. SOUTH AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, 2018-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 290. SOUTH AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, 2018-2030 (USD MILLION)
TABLE 291. SOUTH AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, 2018-2030 (USD MILLION)
TABLE 292. SOUTH AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 293. SOUTH AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 294. SOUTH AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 295. SOUTH AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 296. SOUTH AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 297. SOUTH AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY LATERAL FLOW, 2018-2030 (USD MILLION)
TABLE 298. SOUTH AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 299. SOUTH AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 300. SOUTH AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 301. DENMARK AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 302. DENMARK AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 303. DENMARK AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PHARMACY RETAIL, 2018-2030 (USD MILLION)
TABLE 304. DENMARK AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 305. DENMARK AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY MULTI-DRUG PANEL, 2018-2030 (USD MILLION)
TABLE 306. DENMARK AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SINGLE DRUG, 2018-2030 (USD MILLION)
TABLE 307. DENMARK AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 308. DENMARK AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 309. DENMARK AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 310. DENMARK AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 311. DENMARK AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 312. DENMARK AT-HOME

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this At-home Drug of Abuse Testing market report include:
  • Laboratory Corporation of America Holdings
  • Quest Diagnostics Incorporated
  • Abbott Rapid Diagnostics
  • Premier Biotech, LLC
  • American Screening Corporation
  • Express Diagnostics International, LLC
  • Access Bio Inc.
  • Diagnostic Automation/Cortez Diagnostics, Inc.
  • Certest Biotec S.L.
  • Nal von Minden GmbH

Table Information

Report AttributeDetails
No. of Pages198
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.1 Billion
Forecasted Market Value ( USD ) by 2030 $ 4.38 Billion
Compound Annual Growth Rate7.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Drug of Abuse Testing Market by Sample Type, Test Technology, End User, Drug Panel - Global Forecast to 2030 - Product Image

Drug of Abuse Testing Market by Sample Type, Test Technology, End User, Drug Panel - Global Forecast to 2030

  • Report
  • 196 Pages
  • Global
From
Drug of Abuse Testing Market (By Product Type, Sample / Test Type, Drug Type, End Users / Setting Type, Country Analysis), Regulatory Status, Recent Developments, Company Profiles - Forecast to 2032 - Product Image

Drug of Abuse Testing Market (By Product Type, Sample / Test Type, Drug Type, End Users / Setting Type, Country Analysis), Regulatory Status, Recent Developments, Company Profiles - Forecast to 2032

  • Report
  • 235 Pages
  • Global
From
At-Home Drug of Abuse Testing Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F - Product Image

At-Home Drug of Abuse Testing Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Drug of Abuse Testing Market by Product Type, Sample, Drug, and End User - Global Market Size, Segmental Analysis, Regional Overview, Company Share Analysis, Leading Company Profiles and Market Forecast, 2025-2035 - Product Image

Drug of Abuse Testing Market by Product Type, Sample, Drug, and End User - Global Market Size, Segmental Analysis, Regional Overview, Company Share Analysis, Leading Company Profiles and Market Forecast, 2025-2035

  • Report
  • 220 Pages
  • Global
From
Drug Abuse Testing - Global Strategic Business Report - Product Image

Drug Abuse Testing - Global Strategic Business Report

  • Report
  • 173 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.